Jamjoom Pharmaceuticals Factory Company (4015.SR) — Balance sheet
Assets, liabilities, and shareholders' equity for Jamjoom Pharmaceuticals Factory Company — annual and quarterly history.
| Metric (SAR Millions) | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | 262↓8.0% | 284↑101.4% | 141↑25.4% | 113↓52.2% | 236 | |
| Short-Term Investments | 0.64↓87.7% | 5↑0.9% | 5↑739.0% | 0.61↑244.2% | 0.18 | |
| Cash & Short-Term Investments | 262↓9.4% | 289↑97.8% | 146↑29.2% | 113↓52.0% | 236 | |
| Net Receivables | 455↑26.1% | 361↓7.3% | 389↓3.9% | 405↓10.9% | 455 | |
| Accounts Receivable | 444↑33.5% | 332↓5.7% | 352↓4.0% | 367↓12.3% | 418 | |
| Other Receivables | 12↓59.4% | 29↓21.8% | 37↓2.9% | 38↑4.1% | 37 | |
| Inventory | 271↑15.8% | 234↑77.4% | 132↓2.4% | 135↑4.6% | 129 | |
| Prepaid Assets | 19↓6.8% | 21↑25.1% | 17↑434.8% | 3↑21.8% | 3 | |
| Other Current Assets | 21↑798.3% | 2↓40.6% | 4↓90.8% | 43↑4.5% | 41 | |
| Total Current Assets | 1,029↑13.5% | 907↑31.8% | 688↓1.7% | 700↓17.4% | 847 | |
| Property, Plant & Equipment | 674↓3.5% | 698↓1.0% | 705↓1.2% | 714↑16.3% | 614 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 12↓11.6% | 13↓9.6% | 14↓2.4% | 15↓10.6% | 17 | |
| Goodwill & Intangible Assets | 12↓11.6% | 13↓9.6% | 14↓2.4% | 15↓10.6% | 17 | |
| Long-Term Investments | 57↑57.4% | 36↑842.3% | -5↓244.7% | 3↓7.9% | 4 | |
| Tax Assets | 0.00 | 0.00 | 0.00↓100.0% | 0.61 | 0.00 | |
| Other Non-Current Assets | 0.64 | 0.00↓100.0% | 5 | 0.00↓100.0% | 15 | |
| Total Non-Current Assets | 743↓0.6% | 747↑3.9% | 720↓1.8% | 733↑12.9% | 649 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Assets | 1,772↑7.1% | 1,654↑17.5% | 1,408↓1.7% | 1,432↓4.2% | 1,496 | |
| Liabilities | ||||||
| Total Payables | 72↓22.9% | 93↑63.2% | 57↓6.9% | 62↓1.5% | 62 | |
| Accounts Payable | 39↓42.9% | 68↑70.9% | 40↓4.8% | 42↓0.2% | 42 | |
| Other Payables | 33↑30.4% | 26↓27.1% | 35↓11.3% | 39↓4.1% | 41 | |
| Accrued Expenses | 0.00↓100.0% | 67↑71.2% | 39↑36.9% | 28↓22.9% | 37 | |
| Short-Term Debt | 0.26↓88.0% | 2↑147.8% | -5↓141.2% | 11↓88.3% | 95 | |
| Current Lease Obligations | 0.26↑6.5% | 0.25↑4.5% | 0.24↓5.6% | 0.25↓4.4% | 0.26 | |
| Tax Payables | 29↑12.9% | 26↑43.9% | 18↓10.2% | 20↓10.6% | 22 | |
| Deferred Revenue | 0.00↓100.0% | 4↓95.5% | 84↓9.3% | 93↓3.4% | 96 | |
| Other Current Liabilities | 129↑854.0% | 14↓55.5% | 30↓36.4% | 48↑19.5% | 40 | |
| Total Current Liabilities | 202↑12.1% | 180↑41.7% | 127↓8.2% | 138↓42.1% | 239 | |
| Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Lease Obligations | 2↓15.0% | 2↓10.2% | 2↑39.8% | 2↓12.7% | 2 | |
| Non-Current Deferred Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Liabilities | 77↑14.4% | 68↑8.9% | 62↑2.6% | 61↓19.8% | 76 | |
| Total Non-Current Liabilities | 79↑13.5% | 70↑8.2% | 65↑3.6% | 62↓19.6% | 78 | |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Lease Obligations | 2↓12.8% | 2↓8.9% | 3↑34.0% | 2↓11.7% | 2 | |
| Total Liabilities | 281↑12.5% | 250↑30.4% | 192↓4.5% | 201↓36.6% | 317 | |
| Equity | ||||||
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock | 0.00↓100.0% | 41↑409.6% | 8 | 0.00 | 0.00 | |
| Common Stock | 700↑0.0% | 700↑0.0% | 700↑600.0% | 100↑0.0% | 100 | |
| Retained Earnings | 884↑18.6% | 745↑42.1% | 524↓53.2% | 1,120↑5.3% | 1,063 | |
| Additional Paid-In Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Accumulated Other Comprehensive Income | -93 | 0.00↑100.0% | -8↓165.6% | 12↓25.5% | 16 | |
| Other Stockholders' Equity | 0.00↑100.0% | -81↓409.6% | -16 | 0.00 | 0.00 | |
| Total Stockholders' Equity | 1,491↑6.1% | 1,404↑15.5% | 1,216↓1.2% | 1,232↑4.5% | 1,179 | |
| Total Equity | 1,491↑6.1% | 1,404↑15.5% | 1,216↓1.2% | 1,232↑4.5% | 1,179 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities & Equity | 1,772↑7.1% | 1,654↑17.5% | 1,408↓1.7% | 1,432↓4.2% | 1,496 | |
| Balance Sheet Summary | ||||||
| Total Investments | 57↑39.3% | 41↑16350.4% | 0.25↓93.7% | 4↑3.8% | 4 | |
| Total Debt | 2↓54.3% | 5↑73.8% | 3↑34.0% | 2↓98.0% | 97 | |
| Net Debt | -260↑7.2% | -280↓101.9% | -139↓25.2% | -111↑20.0% | -138 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.